Clinical trial
A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related…
NCT00242359 · Bernstein Clinical Research Center, Other · Withdrawn
Key facts
| NCT number | NCT00242359 |
|---|---|
| Title | A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma |
| Official title | A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma |
| Lead sponsor | Bernstein Clinical Research Center, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Allergy Induced Asthma |
| Intervention type | Drug |
| Interventions | omalizumab |
| Enrollment | 0 |
| Start date | Nov 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Oct 20, 2005 |
| Last update posted | Jul 10, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: